| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advisory Board and Contents
|
|
|
|
45 |
6 |
p. i-ii
|
artikel
|
| 2 |
Anticancer drugs: How to select small molecule combinations?
|
Nussinov, Ruth
|
|
|
45 |
6 |
p. 503-519
|
artikel
|
| 3 |
Defeating MYC with drug combinations or dual-targeting drugs
|
Thompson, Philip E.
|
|
|
45 |
6 |
p. 490-502
|
artikel
|
| 4 |
Directions to overcome therapy resistance in cancer
|
Nussinov, Ruth
|
|
|
45 |
6 |
p. 467-471
|
artikel
|
| 5 |
Eflornithine for treatment of high-risk neuroblastoma
|
Jiang, Jianxiong
|
|
|
45 |
6 |
p. 577-578
|
artikel
|
| 6 |
Emerging paradigms and recent progress in targeting ErbB in cancers
|
Stoup, Nicolas
|
|
|
45 |
6 |
p. 552-576
|
artikel
|
| 7 |
Emerging targets in lipid metabolism for cancer therapy
|
Terry, Alexander R.
|
|
|
45 |
6 |
p. 537-551
|
artikel
|
| 8 |
Enhancing oncogenic signaling to kill cancer cells
|
Noeparast, Maxim
|
|
|
45 |
6 |
p. 475-477
|
artikel
|
| 9 |
Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities
|
Konen, Jessica M.
|
|
|
45 |
6 |
p. 520-536
|
artikel
|
| 10 |
Malolactone strikes: K-Ras-G12D's Achilles' heel
|
Adamopoulos, Christos
|
|
|
45 |
6 |
p. 472-474
|
artikel
|
| 11 |
Subscription and Copyright Information
|
|
|
|
45 |
6 |
p. e1
|
artikel
|
| 12 |
Tackling therapy resistance in cancer
|
Madukwe, Jerry C.
|
|
|
45 |
6 |
p. 465-466
|
artikel
|
| 13 |
TNIK’s emerging role in cancer, metabolism, and age-related diseases
|
Ewald, Collin Y.
|
|
|
45 |
6 |
p. 478-489
|
artikel
|
Tijdschrift beschrijving